Results

Total Results: 191 records

Showing results for "aspirin".

  1. S158 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s158.pdf
    October 01, 2007 - adjust for 5 potential confounders not measured in the administrative claims data (smoking, obesity, aspirin … Demographics X X X Diagnoses X X X Procedures X X X Prescriptions X X X Visits X X X Smoking — — X Aspirin
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
    January 01, 2020 - smoking cessation: behavioral and pharmacotherapy interventionsb Adults Cardiovascular disease Aspirin … cancer screening 0 0 0 0 1 Tobacco smoking cessation 0 3 1 2 0 Cardio- vascular disease Aspirin
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
    March 01, 2012 - is that venous thromboembolism prophylaxis after total hip and knee replacement with warfarin or aspirin … Use of LMWH (compared with aspirin and mechanical device) ? … Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin. … The 2008 ACCP guidelines gave a Grade 1A recommendation against aspirin as TP for any patient group … and the 2010 UK NICE guidelines do not include aspirin as TP for any patient group.1,8 There are no
  4. effectivehealthcare-admin.ahrq.gov/products/prioritization-patient-safety-practices
    January 01, 2024 - Prevention of Delirium in Older Hospitalized Patients Venous thromboembolism Post-Surgical Prophylaxis Using Aspirin
  5. effectivehealthcare-admin.ahrq.gov/products/methods-guidance-applicability/methods
    May 01, 2020 - For example, evidence of the benefits of aspirin for prevention of cardiovascular events from patients … patients with and without heart disease may be useful for estimating the gastrointestinal risks of aspirin
  6. effectivehealthcare-admin.ahrq.gov/products/coronary-stents-outcomes/research
    January 01, 2020 - Pre-Procedural Shock 3675 (1.7%) 1746 (3.9%) <0.001 2.1 2.1 NS Pre-Procedural Aspirin … Hispanic 1.138 1.018 1.272 Race, Asian 1.206 1.037 1.401 Contraindication to Aspirin
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
    March 01, 2017 - Nonsteroidal Anti- Inflammatory Drugs (NSAIDs) • No evidence was available for the effect of low-dose aspirin … on MCI or CATD incidence. • Low-strength evidence shows no benefit for low-dose aspirin on brief cognitive
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
    March 01, 2017 - Nonsteroidal Anti- Inflammatory Drugs (NSAIDs) • No evidence was available for the effect of low-dose aspirin … on MCI or CATD incidence. • Low-strength evidence shows no benefit for low-dose aspirin on brief cognitive
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
    January 01, 2011 - For example, evidence of the benefits of aspirin for prevention of cardiovascular events from patients … patients with and without heart disease may be useful for estimating the gastrointestinal risks of aspirin
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
    January 01, 2011 - For example, evidence of the benefits of aspirin for prevention of cardiovascular events from patients … patients with and without heart disease may be useful for estimating the gastrointestinal risks of aspirin
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
    August 01, 2016 - American adults are increasingly likely to be treated with statins, antihypertensives, and low-dose aspirin … mass index, BP, diabetes, kidney disease, other nutrients or supplements, and drugs (e.g., statins, aspirin … No studies explicitly compared the interaction of n-3 FA intake (or biomarker level) with aspirin intake … mass index, BP, diabetes, kidney disease, other nutrients or supplements, and drugs (e.g., statins, aspirin … data may be confounded by shifts over time in concomitant therapy to reduce CVD risk (e.g., statins, aspirin
  12. effectivehealthcare-admin.ahrq.gov/products/back-pain-treatment/research-protocol
    December 01, 2019 - thereof) Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, celecoxib, acetylsalicylicacid (aspirin) Nonopioid analgesics, such as acetaminophen Opioid analgesics, such as oxycodone,
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - For example, in an SR of aspirin use for prevention of cardiovascular disease and colorectal cancer, … 40 NRSIs (and RCTs) were excluded if they did not report on a comparison between aspirin and a non-aspirinAspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Evidence Update for the U.S
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - For example, in an SR of aspirin use for prevention of cardiovascular disease and colorectal cancer, … 40 NRSIs (and RCTs) were excluded if they did not report on a comparison between aspirin and a non-aspirinAspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Evidence Update for the U.S
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - controlled trials Drug development Combination therapies: e.g., medications + diet; medications + aspirin … Combination therapies (e.g., aspirin + prescription medication) 50.0% (3) 33.3% (2) 16.7% … Combination therapies (e.g., aspirin + tamoxifen) 27.3% (3) 36.4% (4) 36.4% (4) Q20. … Drug development 74, 224, 225 Combination therapies: e.g., medications + diet; medications + aspirin … For example, the effects of adding aspirin in conjunction with tamoxifen or raloxifene could improve
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - Similarly, we included antiplatelet agents aspirin and clopidogrel; as well as the anticoagulant warfarin … bleeding comparing prophylactic dabigatran with enoxaparin in patients concomitantly treated with aspirin … major bleeding with prophylactic dabigatran or enoxaparin in patients concomitantly treated with aspirin … The question of elevated risk of bleeding with dual therapy with prophylactic anticoagulation and aspirin
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
    August 08, 2017 - Placebo (n=381) *Excluded studies arms: aspirin, aspirin + rofecoxib 12 Industry MacDonald, 2017 Multinational
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
    January 01, 2010 - 0.001 10.9 11.1 NS Pre-Procedural Shock 3675 (1.7%) 1746 (3.9%) <0.001 2.1 2.1 NS Pre-Procedural Aspirin … 0.760 0.896 Race, Hispanic 1.138 1.018 1.272 Race, Asian 1.206 1.037 1.401 Contraindication to Aspirin
  19. effectivehealthcare-admin.ahrq.gov/products/renal-update/research-protocol
    January 01, 2020 - recommend statins to lower low density lipoprotein (LDL) cholesterol and antiplatelet agents, such as aspirin
  20. effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research-protocol
    December 01, 2019 - been shown to inhibit blood coagulation. 11,15,20,21 When coupled with common anticoagulants like aspirin … Effects of dietary supplements on aspirin and other antiplatelet agents: An evidence-based approach.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: